Skip to main content

Table 3 Mean estimated within-person changes (with 95% confidence intervals) associated with use of oyster mushrooms*

From: Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy

 

Day 14

mean change

(95% CI)

Day 28

mean change

(95% CI)

Day 42

mean change

(95% CI)

Day 56

mean change

(95% CI)

Total Cholesterol

-9.72

(-20.66, 1.23)

-12.99

(-26.89, 0.91)

4.33

(-11.39, 20.04)

-1.70

(-17.41, 14.02)

Non-HDL

-8.06

(-18.72, 2.60)

-10.89

(-23.51, 1.73)

2.06

(-13.24, 17.35)

-4.25

(-19.06, 10.56)

VLDL

2.80

(-4.47, 10.06)

3.47

(-4.08, 11.03)

5.86

(-3.45, 15.16)

-4.07

(-10.73, 2.59)

LDL

-8.73

(-20.41, 2.96)

-5.10

(-17.19, 6.99)

2.01

(-12.23, 16.25)

6.89

(-9.29, 23.07)

HDL

-1.65

(-3.54, 0.23)

-2.10

(-5.05, 0.85)

2.27

(-0.70, 5.24)

2.55

(-0.07, 5.17)

Triglycerides

-22.79

(-102.56, 56.98)

-16.64

(-86.78, 53.50)

-13.64

(-100.67, 73.40)

-62.98

(-120.92, -5.05)

Glucose

0.23

(-5.68, 6.13)

1.90

(-1.77, 5.57)

4.59

(-1.51, 10.68)

-0.12

(-6.25, 6.01)

AST

-1.37

(-5.60, 2.86)

-4.62

(-9.65, 0.41)

-2.20

(-7.34, 2.95)

-2.09

(-7.43, 3.26)

ALT

-1.31

(-4.22, 1.62)

-3.33

(-6.85, 0.18)

1.56

(-3.29, 6.41)

0.36

(-4.44, 5.15)

  1. * Statistically significant (p < 0.05) changes noted in bold.